Common prostate drug may help prevent Parkinson s disease
By (0)
While scientists still don t know what causes Parkinson s disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness.
A team led by scientists at the University of Iowa, working in collaboration with researchers in Denmark and China, found that the drug terazosin and similar medications may have the potential to prevent or delay this debilitating neurodegenerative condition.
Advertisement
The researchers found that men taking terazosin were between 12% and 37% less likely to develop Parkinson s disease during the follow-up period than men taking another drug for an enlarged prostate called tamsulosin.
Posted: Feb 09, 2021 6:00 AM CT | Last Updated: February 9
The Yukon Employees Union president said continuing care employees are being told to use their sick days should they experience symptoms after receiving their second dose of the Moderna vaccine, which he says is unfair.(Andrew Vaughan/The Canadian Press)
The head of the Yukon Employees Union says many continuing care staff are missing work because of side effects from the COVID-19 vaccine.
Union president Steve Geick said Tuesday there was a big spike in the number of continuing care workers calling in sick last week. He said 60 per cent of staff at the Thompson Centre in Whitehorse missed work on Feb. 5.
Cancer Chemotherapy Market Value Anticipated To Reach US$ 74.3 Billion By 2027: Acumen Research and Consulting Acumen Research and Consulting Pune, INDIA
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled
“Cancer Chemotherapy Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020-2027”
LOS ANGELES, Feb. 08, 2021 (GLOBE NEWSWIRE) The
Global Cancer Chemotherapy Market is expected to grow at a CAGR of around 11.4% from 2020 to 2027 and reach the market value of over US$ 74.3 Bn by 2027.
The rising prevalence of cancer worldwide is primarily driving the market growth. In 2018, cancer was the second leading cause of death globally and was responsible for around 9.6 million deaths globally. About 1 in 6 deaths is due to cancer worldwide. According to the WHO estimates 2018, approximately 70% of deaths from cancer occur in low and middle-income countries. T
While scientists still don t know what causes Parkinson s disease, new research shows an association between a drug that some men take for an enlarged prostate condition and a reduced risk of developing the illness.